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Problem Definition

Transfusions provide benefit to many patients in
many settings but may be complicated by transfusion
reactions (TR). There are no evidence-based studies
to support premedicating patients that have not
previously experienced a TR(1). Premedication with
acetaminophen and diphenhydramine are associated
with potential risks and cost implications over
time(2). Premedications may also mask the symptoms
of TR such as a fever or itching/hives, preventing the
identification of a more severe TR in a timely manner.
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Proposed Intervention

To eliminate premedications, we plan to:
• Hang informational pamphlets in the OIC
• Create an in-service course for OIC staff detailing
proper transfusion history documentation and
disadvantages of premedications
• To ensure ongoing compliance, we can create a
myJeffHub-Learning course that will be mandatory
for new OIC staff as well as a required annual
refresher
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Data Collection

We gathered transfusion data from our outpatient
infusion centers (OIC): 925 Chestnut Street, the
Bodine Center, and JHN Infusion Center. In
December 2019, 96 unique patients were transfused
blood products with a total of 205 transfusion
episodes. Of the 96 patients transfused, 82 (85%)
were given or offered premedications, of which only
14 (17%) patients had a prior TR reported (figure 1).
When reviewing individual transfusion episodes, we
noted that during 161 (79%) of 205 transfusion
episodes, patients were given or offered
premedications (figure 2). If this trend were
extrapolated over one year, more than 1000 patients
are likely to be affected.
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Aims For Improvement

Measurement Strategy

Our aim is to eliminate premedication prior to
outpatient transfusions in patients without a prior
transfusion reaction by 75% within 1 year.

We will track the transfusion episodes after
educational material has been distributed at the
infusion centers. For each episode, the patient’s chart
will be reviewed for premedication orders, the
provider who placed the order, and documentation of
a previous TR. We may publish individual provider
and team metrics to track progress and encourage
compliance.

Implementation Plan

The faculty mentors for this project will be Dr. Julie
Karp and Dr. Alexis Peedin. This project will be an
interdisciplinary collaboration between Transfusion
Medicine, Medical Oncology, and nursing education.
Our upcoming Transfusion Medicine fellow, Dr.
Yuanzheng (Andrew) Gao, will take the lead of this
project as of July 1, 2020. We expect the
implementation of this program to begin on July 1st
and continue on an ongoing basis.
We estimate a budget of no more than $2000 to:
• cover the expenses of educational material
• myJeffHub-Learning course creation
• refreshments for live courses

We will follow progress every 3 months after
implementation. If we do not achieve our expected
results, we plan to identify the group(s) involved and
aid in re-educating them.
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